Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
about
Multifunctional polymeric micelles for delivery of drugs and siRNA.Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity.Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cellsFabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells.Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.'Click' synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeuticsRGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells.Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma.Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma.pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors.Dextran conjugates in drug delivery.Tailoring polymeric micelles to optimize delivery to solid tumors.Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy.Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles.Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage.E-selectin-targeted Sialic Acid-PEG-dexamethasone Micelles for Enhanced Anti-Inflammatory Efficacy for Acute Kidney InjuryDoxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.Preparation, Characterization and Evaluation of α-Tocopherol Succinate-Modified Dextran Micelles as Potential Drug CarriersTriphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria.Cellular Uptake and Intracellular Cargo Release From Dextran Based Nanogel Drug Carriers.Significant role of cationic polymers in drug delivery systems.Atorvastatin-loaded micelles with bone-targeted ligand for the treatment of osteoporosis.Redox-sensitive shell-crosslinked polypeptide-block-polysaccharide micelles for efficient intracellular anticancer drug delivery.Dually sensitive dextran-based micelles for methotrexate deliveryEffect of Molecular Weight and Molar Ratio of Dextran on Self-Assembly of Dextran Stearate Polymeric Micelles as Nanocarriers for Etoposide
P2860
Q30438973-0A3E6565-8E23-4249-915F-39C58DEB813EQ30913776-C07EF8CF-99B2-4ED0-A69C-0B892434F0CEQ33427938-D72B5BEB-6B2F-4403-A6E0-1617F2BFC5F3Q33883851-A5AA3A64-4429-4073-AC87-8C36047E4A8AQ34124903-53A918B3-6329-4957-ABE8-C5B727C9F684Q34384085-EBDB96D1-4039-433C-88A7-3EE4C8CB6CA1Q34437440-3B8447B3-1975-417A-924A-A2B827875B7CQ35001775-3C11FA84-D9C1-45DF-8B45-69E02F0CA6E0Q35122756-9AC17A70-3E6C-42BD-8F82-137E588CAA8EQ35377803-EF94CAE5-2CF0-456A-8D37-7C202F3FA853Q35380806-0E2686B3-2898-4CAE-A702-0F26108FE735Q35692091-E7B76A27-67E7-482B-9A1C-715D2BECB269Q35815100-26138AD4-5764-4D98-8C1E-031FD6AEBD3EQ36333607-25468C80-1871-44F0-B12E-2B2361441BDDQ36750790-746B21A8-5648-411F-A86F-BAFDD929716BQ37995245-A182C12F-A5D1-4B43-84C2-A0C185015F30Q38038896-E4ED6BF4-67B7-4EBB-8DF8-F5809AD807C4Q38717725-AC0DD687-6178-45BD-AE3F-469B174CD6ACQ38809044-0C218695-B35A-44AA-BE3C-52234F00744EQ38975631-D51AB42F-0D5E-4224-AD04-657CF1174F58Q39009550-71A56CB2-383A-4131-878A-A84C3A69AB2AQ39102887-5701744D-58B9-40E1-AF72-E158239E771FQ40980366-192DD7EE-8FF2-49C9-BEB3-FB49487E9B31Q41545913-8F887253-E89C-4DD3-B179-C391AF703283Q42228320-C60C91B7-65F6-4706-91B0-9F17CC5CE0B7Q42255827-DE584121-8172-4F0A-AC49-E5ADA38A2287Q43096318-F9BA8164-09FA-4F75-8A70-9873A4B0FE70Q47380913-2D1A506D-117A-4623-B114-33CE79C65D60Q47556330-E982A634-D7AD-490B-8B83-A6CD2F060BF6Q53099052-0D68D03C-2A28-405A-B55E-016B430B5658Q57369542-789459FA-791A-481E-9BA5-3DDE13B63748Q58909468-83167A60-60B6-4072-BD24-2E8C0688615F
P2860
Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@en
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@nl
type
label
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@en
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@nl
prefLabel
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@en
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@nl
P2093
P356
P1433
P1476
Synthesis and antitumor activi ...... cellular doxorubicin delivery.
@en
P2093
Fu-Qiang Hu
Yong-Zhong Du
P304
P356
10.1021/NN100927T
P407
P577
2010-10-12T00:00:00Z